Thu, 09 Jun|
Endorsing Clinical Trials in Africa
Following the success of the last episode in our Conversations with Black Pharma series, 'Pharma in Africa', we're delving deeper into the industry on the continent by discussing 'Endorsing Clinical Research in Africa'.
Time & Location
09 Jun 2022, 19:00 BST
About the event
Following the success of the last episode in the Conversations with Black Pharma series, 'Pharma in Africa', we're delving deeper into the industry on the continent by discussing 'Endorsing Clinical Research in Africa'.
Join us, as our guest Bukky Apampa (Study Management Team Lead, Roche), will share her experience of setting up a clinical trial in Africa, main issues that were faced, lessons learnt and future plans for research in Africa.
Bukky Apampa is a Study Management Team Lead within Roche's product research and early development. Bukky was instrumental in initiating Roche's conduct of its first early phase clinical trial in Africa and has worked across several therapeutic areas including Neuroscience, Inflammation and immunology and Oncology.
She's had the opportunity to work on some breakthrough treatments such as Atezolizumab in triple negative breast cancer and ocrelizumab in multiple sclerosis. Bukky has 16 years experience of working in clinical research both at the academic, charity and pharmaceutical settings.
Bukky is passionate about doing what is right for patients and believes that everyone should have access to the medical care they need wherever they live.
Adeola Adelusi - Host
Adeola has worked in clinical research for 6 years, with experience spanning multiple therapy areas. He is passionate about personal development and has worked at Richmond Pharmacology, Novartis, Re:Cognition Health, Astra Zeneca and Roche.
In his spare time, Adeola is an avid guitar player and creative that loves to bring people together.
‘Conversations with Black Pharma’ is a series of informal conversations on Pharma and everything related. From clinical trial diversity to social media and work, we are discussing it all and laying it bare.